Glenmark Pharmaceuticals strengthens on the BSE

22 May 2018 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs. 502.70, up by 1.85 points or 0.37% from its previous closing of Rs. 500.85 on the BSE.

The scrip opened at Rs. 501.00 and has touched a high and low of Rs. 504.00 and Rs. 500.00 respectively. So far 2890 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 748.00 on 28-Jul-2017 and a 52 week low of Rs. 494.50 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 529.90 and Rs. 494.50 respectively. The current market cap of the company is Rs. 14132.39 crore.

The promoters holding in the company stood at 46.54%, while Institutions and Non-Institutions held 37.37% and 16.10% respectively.

Glenmark Pharmaceuticals has submitted a New Drug Application (NDA) to the US Food & Drug Administration (USFDA) for its leading respiratory pipeline candidate Ryaltris, an investigational fixed-dose combination nasal spray of an antihistamine and a steroid, as a treatment for seasonal allergic rhinitis (SAR) in patients 12 years of age and older.

Ryaltris (olopatadine hydrochloride (665 mcg) and mometasone furoate (25 mcg)), formerly GSP 301 Nasal Spray, has been conditionally accepted by the FDA as the brand name.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

2016.90 30.15 (1.52%)
30-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1595.00
Dr. Reddys Lab 1218.40
Cipla 1323.95
Zydus Lifesciences 885.20
Lupin 2151.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×